Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (ASSURE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2013 by Medical Care Center Prof. Mathey, Prof. Schofer, Ltd..
Recruitment status was  Active, not recruiting
Abbott Vascular
Information provided by (Responsible Party):
Detlef Mathey, Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. Identifier:
First received: April 17, 2012
Last updated: March 20, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2016
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)